European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Oxford Biodynamics plc, Oxford

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Oxford Biodynamics plc
Oxford Biodynamics Ltd.

Identification

Chp
Companies House 06227084
Stockp
OXBOF OBD.L
Lei
2138005Y1TK258O5U928

Address

3140 Rowan Place John Smith Drive, Oxford Business Park South, Oxford OX4 2WB, United Kingdom
the Quorum Alec Issigonis Way Oxford Business Park North Oxford, United Kingdom

Corporate purpose

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment … Show more

Financial performance

History

Persons

Marketing & Tech

Network

Loading network

Legal Structure

Current legal representatives (6)
This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

Financials

Key Performance Indicators: Financial (5) · Mktg & Tech (5)

The following indicators are on file for this company: Base/share capital · Total assets · Earnings · Revenue · Revenue CAGR · Return on sales · Equity · Equity ratio · Return on equity · Taxes · Cash on hand · Receivables · Liabilities · Patents

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Annual report  

Publications

13 Apr 2026
Termination of appointment of Stephen Charles Diggle as a director
7 Feb 2026
Group of companies' accounts made up to 2025-09-30
27 Nov 2025
Resolution of removal of pre-emption rights · Resolution of allotment of securities
24 Nov 2025 also 13/10/2023, 28/04/2023, 27/10/2021, 11/02/2019, 18/10/2018, 27/06/2018, 11/04/2018, 02/01/2018, 12/12/2017, 12/12/2016, 10/07/2015, 22/04/2014, 02/04/2014, 24/11/2011
Statement of capital following an allotment of shares
30 Sept 2025
Balance sheet for 30/09/2025 · Earnings statement for 30/09/2025
22 Jul 2025
Director's details changed for Mr Peter Eric Presland
1 May 2025 also 09/05/2023, 06/05/2022, 27/04/2021, 04/05/2020, 08/05/2019, 30/04/2018
Confirmation statement made with no updates
23 Apr 2025
Patent: Chromosome interaction markers
27 Mar 2025
Director: Peter Eric Presland
18 Mar 2025
No longer Director: Matthew A. Wakefield
14 Mar 2025
Annual report for the year ending 30/09/2024
10 Mar 2025
Director: Iain Gladstone Ross
4 Feb 2025
Statement of capital following an allotment of shares · Memorandum and Articles of Association …
14 Jan 2025
No longer Director: Jon A. J. Burrows
30 Sept 2024
Balance sheet for 30/09/2024 · Earnings statement for 30/09/2024
Year 2024 in Epobase
5 European patent filings: Typing Method for the Diagnosis of Alzheimer's Disease …
9 May 2024
Confirmation statement made with no updates · Director's details changed for Mr Alexandre Akoulitchev …
28 Mar 2024
Annual report for the year ending 30/09/2023
30 Sept 2023
Balance sheet for 30/09/2023 · Earnings statement for 30/09/2023
23 Aug 2023
Patent: Detection of Chromosome Interaction Relevant to Breast Cancer
21 Mar 2023
Annual report for the year ending 30/09/2022
30 Sept 2022
Balance sheet for 30/09/2022 · Earnings statement for 30/09/2022
16 Mar 2022
Annual report for the year ending 30/09/2021
6 Jan 2022
Patent: Chromosome Interactions
11 Oct 2021
Patent: Disease Marker
30 Sept 2021
Balance sheet for 30/09/2021 · Earnings statement for 30/09/2021
27 Sept 2021
Address
1 Jul 2021 in Hor
EU funding (€249,375): Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States
2 Jun 2021
Patent: Detecting a Chromosome Conformation AS Marker for Fibrosis, E.G. Scleroderma
21 Apr 2021
Annual report for the year ending 30/09/2020
5 Jan 2021
Termination of appointment of Christian Gurth Hoyer Millar as a director
16 Dec 2020
No longer Director: Peter Pack
15 Dec 2020
Director: Matthew A. Wakefield
30 Sept 2020
Balance sheet for 30/09/2020 · Earnings statement for 30/09/2020
10 Sept 2020
Patent: Diagnostic Chromosome Marker
6 May 2020
Patent: Chromosome Conformation Markers of Prostate Cancer and Lymphoma
30 Apr 2020
Director's details changed for Dr Peter Pack · Director's details changed for Mr Christian Gurth Hoyer Millar …
29 Apr 2020
Address
24 Mar 2020
Director: Jon A. J. Burrows
3 Feb 2020
Annual report for the year ending 30/09/2019
21 Oct 2019
Patent: Chromosome Biomarker
30 Sept 2019
Balance sheet for 30/09/2019 · Earnings statement for 30/09/2019
30 Jul 2019
Director's details changed for Dr Peter Pack
3 Jun 2019
No longer Director: Alison C. Kibble
25 Apr 2019
Director's details changed for Mrs Alison Caroline Kibble · Director's details changed for Mr Alexandre Akoulitchev
24 Apr 2019
Director's details changed for Mr Christian Gurth Hoyer Millar
10 Apr 2019
Director's details changed for Dr David Mark Anthony Holbrook · Director's details changed for Dr Peter Pack
8 Apr 2019
Director: David M. A. Holbrook, Peter Pack · No longer Director: David J. Williams
30 Jan 2019
Annual report for the year ending 30/09/2018
11 Dec 2018
No longer Secretary (1) · Secretary: Alder Demain & Akers Ltd
1 Nov 2018 in Hor
EU funding: Predictive Epigenetics: Fusing Theory and Experiment
1 Oct 2018
Patent: Biomarker
30 Sept 2018
Balance sheet for 30/09/2018 · Earnings statement for 30/09/2018
12 Apr 2018 also 05/01/2017
Resolution of removal of pre-emption rights · Resolution of authority to purchase a number of shares …
16 Mar 2018
Annual report for the year ending 30/09/2017
30 Nov 2017
Patent: Application of Epigenetically Altered Chromosomal Interactions in Cancer Diagnostics
30 Sept 2017
Balance sheet for 30/09/2017 · Earnings statement for 30/09/2017
15 Sept 2017
Director: Paul L. Stockdale
24 Jul 2017
Companies House - Filing
6 Jul 2017
No longer Director: Kathleen Joy Long
4 Jun 2017
Annual report for the year ending 30/09/2016
8 May 2017
Confirmation statement made with updates
29 Mar 2017
Resolution of varying share rights or name
13 Oct 2016
Reg­is­tra­tion: 13/10/2016 · Name: Oxford Biodynamics plc
13 Oct 2016
Balance Sheet
11 Oct 2016
Director: Kathleen Joy Long, David J. Williams
7 Oct 2016
Appointment of Mr Stephen Charles Diggle as a director
5 Oct 2016
No longer Director: Juliet Thompson · Address
30 Sept 2016
Balance sheet for 30/09/2016 · Earnings statement for 30/09/2016
28 Sept 2016
Secretary (1)
22 Sept 2016
Statement of capital following an allotment of shares · Consolidation of shares
9 Sept 2016
No longer Secretary: Aldwych Secretaries Ltd
2 Sept 2016
Memorandum and Articles of Association
24 Aug 2016
Statement by Directors · Statement of capital · Solvency Statement dated 15/08/16 …
22 Aug 2016
Appointment of Dr Philip James Boyd as a secretary
7 Jul 2016
Director: Juliet Thompson
24 Jun 2016
Patent: Detection method using chromosome interaction sites
17 Jun 2016
Wordmark: “EPISWITCH“
16 Jun 2016 also 15/11/2012, 03/11/2011, 17/11/2010, 07/11/2009, 29/01/2009
Accounts for a small company made up to 2015-09-30
18 May 2016
Capital: £2,720.00
30 Sept 2015
Balance sheet for 30/09/2015 · Earnings statement for 30/09/2015
8 Sept 2015
No longer Director (1)
29 Jun 2015
Capital: £2,600.00
15 May 2015
Appointment of Dr Philip James Boyd as a director
1 Apr 2015 in Ukri
UK funding (£613,041): Development of prognostic epigenetic biomarkers for ALS.
9 Dec 2014 also 07/11/2013
Total exemption small company accounts made up to 2014-09-30
30 Sept 2014
Balance sheet for 30/09/2014 · Earnings statement for 30/09/2014
3 Sept 2014
Patent: Methods of Detecting Long Range Chromosomal Interactions
8 Jul 2014
Director's details changed for Mr Christian Hoyer Millar
2 May 2014
Capital: £2,600.00
9 Apr 2014
Director (1)
30 Sept 2013
Balance sheet for 30/09/2013 · Earnings statement for 30/09/2013
10 Jun 2013
No longer Director (1)
2 May 2013 also 26/04/2012, 08/06/2011, 20/08/2010
Annual return made up to 2013-04-25 with full list of shareholders
21 Feb 2013
Director's details changed for Alison Caroline Kibble
28 Feb 2012
Address
20 May 2011 also 24/04/2009, 25/06/2007
Resolution of Memorandum and/or Articles of Association
23 Mar 2011
Patent: Verfahren zum Nachweis Chromosomaler Fernwechselwirkungen
7 Oct 2009
Wordmark: “EPISWITCH“
6 May 2009 also 30/04/2008
Return made up to 25/04/09; full list of members
14 Apr 2009 also 09/04/2009, 06/08/2008, 24/06/2008, 12/05/2008, 22/04/2008
Filings
16 Dec 2008
Nc inc already adjusted 11/12/08 · Resolution of increasing authorised share capital …
7 Nov 2008
Director appointed dr heinrich dreismann
29 Apr 2008
Statement of affairs
18 Apr 2008
Resolution of increasing authorised share capital · Resolution of removal of pre-emption rights …
23 Jan 2008
New director appointed · Director resigned
6 Dec 2007
Nc inc already adjusted 28/11/07 · Resolution of removal of pre-emption rights · Resolution of allotment of securities
20 Jun 2007
New director appointed
19 Jun 2007
Address
15 Jun 2007
Accounting reference date extended from 30/04/08 to 30/09/08
25 Apr 2007
Reg­is­tra­tion: 25/04/2007 · Director: Ch. G. Hoyer Millar · Nominee Secretary: Nominee Secretary Ltd
There are no publications matching your search.

Mentions

3 Apr 2025 in Psc
Shareholding: Holos Life Sciences (UK) Ltd
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.